2019-20冠状病毒爆发
药物发现
药品
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
药物开发
2019年冠状病毒病(COVID-19)
爆发
抗病毒药物
产量(工程)
重症监护医学
冠状病毒
风险分析(工程)
药理学
医学
业务
病毒学
生物
生物信息学
内科学
传染病(医学专业)
疾病
材料科学
冶金
作者
Yuanchang Liu,Gaorong Wu,Yiting Yang,Wei Hu,Xiaopeng Peng,Zihan Peng,Jiatao Xia,Xin Xie,Jiuzhong Huang,Weiming Chen
标识
DOI:10.1021/acs.oprd.3c00494
摘要
The outbreak and rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have led to one of the most serious public health crises since the beginning of the 21st century. An oral anti-SARS-CoV-2 drug ensitrelvir was developed with satisfactory antiviral effect and was synthesized via different strategies. This Review summarizes the advantages and disadvantages of the currently reported synthetic strategies for ensitrelvir along with three related key building blocks derivatives from the view of procedure, yield, impurities, safety, and environment. This will provide a novel perspective for further process development and drug discovery.
科研通智能强力驱动
Strongly Powered by AbleSci AI